In repeated measures bioavailability/bioequivalence studies involving two formulations, the underlying measurements, such as the area under the plasma concentration-time curve (AUC) and the maximum plasma concentration ( C), typically have a block compound-symmetric covariance matrix. To test the eq
Heterogeneous Variances in Repeated Measures
โ Scribed by Yuan Wu; Prof. C. A. McGilchrist
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 373 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0323-3847
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Longitudinal data is often collected in clinical trials to examine the e!ect of treatment on the disease process over time. This paper reviews and summarizes much of the methodological research on longitudinal data analysis from the perspective of clinical trials. We discuss methodology for analysin
The summary measures approach to analysing repeated measures is described. The circumstances under which it can be advantageous to use such measures are considered. Strategies for baseline adjustment where there are multiple baselines are examined, as is the choice of appropriate summary statistic.
## Abstract It is interest to compare functions of parameters in nonlinear models for repeated measurements. In a pharmacokinetic model, the maximum value of the model would be a nonlinear function of some unknown parameters. In this paper, simultaneous confidence intervals of functions of paramete